NASDAQ · Medical - Devices

AdaptHealth Corp. (AHCO) Stock

$6.03 -0.54% NASDAQ: AHCO Healthcare

Valuation

MetricValue
Price$6.03
Market Cap$820.70M
P/E Ratio-3.31
P/B Ratio0.55
P/S Ratio0.25
EPS (TTM)$-0.52
52-Week High$13.43
52-Week Low$5.21
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-15.16%
ROA-5.26%
ROCE-0.26%
Gross Margin5.38%
Operating Margin7.26%
Net Margin-7.58%
Debt/Equity1.50
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.5B$3.0B$3.2B$3.3B$3.2B
Operating Profit$226.0M$190.0M$-598.0M$264.0M$186.0M
Net Profit$156.0M$69.0M$-679.0M$90.0M$-71.0M
EPS$0.67$0.50$-5.31$0.61$-0.52
Op Margin9.2%6.4%-18.7%8.1%5.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.3B$5.2B$4.5B$4.5B$4.3B
Total Liabilities$3.2B$3.1B$3.0B$2.9B$2.8B
Cash$150.0M$46.0M$77.0M$110.0M$106.0M
Borrowings$2.4B$2.3B$2.3B$2.1B$1.9B

Latest News

AHCO: What does Argus have to say about AHCO? Argus Research · Jul 15, 2026 AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call Business Wire · Jul 14, 2026 AdaptHealth discloses patient data was stolen in cyberattack MedTech Dive · Jul 7, 2026 AdaptHealth discloses June cyberattack resulting in patient data exposure Medical Device Network · Jul 6, 2026 AdaptHealth Reports Material Cybersecurity Incident MT Newswires · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$276.0M$374.0M$481.0M$542.0M$602.0M
Investing Cash Flow$-2.0B$-803.0M$-695.0M$-616.0M$-686.0M
Financing Cash Flow$-76.0M$-30.0M$-41.0M$-19.0M$-35.0M
Net Cash Flow$50.0M$-103.0M$31.0M$33.0M$-4.0M
Free Cash Flow$72.0M$-18.0M$143.0M$236.0M$219.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.11
EV / EBITDA9.58
FCF Yield12.92%
Quick Ratio0.98
Interest Coverage-0.09
Return 1Y8.61%
Return 3Y-24.30%
Return 5Y-60.44%

Ownership

Insiders Held8.14%
Institutions Held106.71%
Institutions Float Held116.17%
Institutional HolderSharesReport Date
OEP Capital Advisors, LP16,312,6982026-03-31
Blackrock Inc.15,939,9532026-03-31
Deerfield Management Company, L.P11,477,7302026-03-31
Skyknight Capital, L.p.8,580,4432026-03-31
FMR, LLC8,054,6912026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About AdaptHealth Corp.

AdaptHealth Corp. is led by CEO Suzanne Foster, employs 10,500 people, headquartered in US, publicly traded since 2018.

AdaptHealth Corp. (AHCO) stock trades at $6.03 with a market capitalization of $820.70M. The stock is valued at a price-to-earnings (P/E) ratio of -3.31, price-to-book of 0.55, price-to-sales of 0.25. Over the past 52 weeks the stock has ranged between $5.21 and $13.43, and currently trades 55.1% below its 52-week high.

On profitability, AdaptHealth Corp. generates a return on equity (ROE) of -15.16%, return on capital employed of -0.26%, an operating margin of 7.26%, a net profit margin of -7.58%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides